Thus, it is reasonable to think that cancer cells would rather benefit from mutant p53 with enhanced autophagy activation that can serve as a cell survival mechanism during certain conditions, similar to the dual nature of autophagy which confers suppressive role in tumor initiation while aggressive cancers acquire autophagy for growth and survival. The gene discussed is TP53; the disease is neoplasm.